4.6 Article

Hormone Therapy Reduces Recurrence in Stage II-IV Uterine Low-Grade Endometrial Stromal Sarcomas: A Retrospective Cohort Study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

New Insights into Hormonal Therapies in Uterine Sarcomas

Elena Maccaroni et al.

Summary: Uterine sarcomas are rare mesenchymal malignant cancers, and surgery is the main treatment for early-stage disease. Chemotherapy, hormonal therapy, and targeted therapy can be used in the treatment of metastatic cases. ER and PR are usually highly expressed in uterine sarcoma patients and are associated with improved overall survival.

CANCERS (2022)

Article Obstetrics & Gynecology

Does ovarian preservation have an effect on recurrence of early stage low-grade endometrial stromal sarcoma?

Volkan Karatasli et al.

Summary: The study found that ovarian preservation had no effect on the recurrence of stage I low-grade endometrial stromal sarcoma. Lymphadenectomy and adjuvant hormonal treatment do not impact DFS, while adjuvant radiotherapy decreases DFS.

JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2021)

Article Medicine, General & Internal

Complete remission of advanced low-grade endometrial stromal sarcoma after aromatase inhibitor therapy: a case report

Omar F. Altal et al.

Summary: This case describes a 51-year-old Mediterranean woman with low-grade endometrial stromal sarcoma treated with surgical resection and hormonal therapy, achieving partial remission of lung metastasis at 8 months and full remission at 18 months, with no recurrence after 2.5 years. The successful outcome highlights the importance of hormonal therapy in the management of such tumors, without the need for chemotherapy or radiotherapy.

JOURNAL OF MEDICAL CASE REPORTS (2021)

Article Obstetrics & Gynecology

Adjuvant Hormonal Therapy for Low-Grade Endometrial Stromal Sarcoma

Uma Deshmukh et al.

REPRODUCTIVE SCIENCES (2019)

Article Medicine, General & Internal

Hormone therapy following surgery in low-grade endometrial stromal sarcoma: Is it related to a decrease in recurrence rate?

Gunsu Kimyon Comert et al.

JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2019)

Review Obstetrics & Gynecology

The clinical benefits of hormonal treatment for LG-ESS: a meta-analysis

Ran Cui et al.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2019)

Review Oncology

Ovarian preservation for low-grade endometrial stromal sarcoma: a systematic review of the literature and meta-analysis

Dimitrios Nasioudis et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2019)

Review Obstetrics & Gynecology

Fertility-sparing management of low-grade endometrial stromal sarcoma: analysis of an institutional series and review of the literature

Giuseppe Laurelli et al.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2015)

Article Obstetrics & Gynecology

Prognostic significance of steroid receptor positivity and adjuvant progestogen use in endometrial stromal sarcoma

Thomas J. Cade et al.

AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY (2014)

Review Oncology

Hormonal therapy in gynecological sarcomas

Eirini Thanopoulou et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2012)

Article Oncology

Long-term medroxyprogesterone acetate therapy for low-grade endometrial stromal sarcoma

Mika Mizuno et al.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2012)

Review Oncology

Progestin therapy for endometrial cancer: The potential of fourth-generation progestin

Kouji Banno et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2012)

Article Obstetrics & Gynecology

Ovarian preservation in stage I low-grade endometrial stromal sarcomas

AJ Li et al.

OBSTETRICS AND GYNECOLOGY (2005)